Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FHZES
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,655
Award facts
- Contract value 100% obligated
- $10,655.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,655.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, carries no set-aside designation, indicating the award was made through unrestricted competition. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability, with multiple delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division throughout October 2025, reflecting the company's competitive performance across diverse therapeutic categories and product lines. The company's established IDC under PPV-G GEN V, with a $499.999 billion ceiling value and term through December 31, 2036, positions it as a critical supplier for recurring medical supply needs across the military healthcare system. As the sole prime contractor on this award with no identified subcontractors, DMS Pharmaceutical Group directly fulfills the specialized pharmaceutical requirements of Department of Defense operations.
Quick answers
Who was awarded contract SPE2DB26FHZES?
SPE2DB26FHZES was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FHZES worth?
The government has obligated $10,655 on SPE2DB26FHZES.
Is contract SPE2DB26FHZES an order under another contract?
Yes. SPE2DB26FHZES is a delivery order under SPE2DB24D9155, an indefinite delivery contract.
Was contract SPE2DB26FHZES competed?
The extent of competition for SPE2DB26FHZES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award